Showing all 7 results
Research CJC-1295 (No DAC) — a synthetic growth hormone–releasing hormone (GHRH) analog studied for its roles in pulsatile GH release and pituitary signaling. For research use only.
Research CJC-1295 (No DAC) / Ipamorelin Blend — a dual-pathway peptide formulation studied for its roles in growth hormone release, endocrine signaling, and cellular repair. For research use only.
Research CJC-1295 (with DAC) — a synthetic growth hormone–releasing hormone (GHRH) analog conjugated with a Drug Affinity Complex (DAC) for extended half-life and sustained GH release studies. For research use only.
Research Ipamorelin — a selective growth hormone secretagogue (GHS) studied for its targeted stimulation of GH release without significant effects on other pituitary hormones. For research use only.
Research Sermorelin — a synthetic peptide studied as a growth hormone–releasing hormone (GHRH) analog with relevance to growth hormone secretion and pituitary function. For research use only.
Research Tesamorelin / Ipamorelin Blend — a dual-peptide formulation studied for its combined roles in growth hormone–related pathways, cellular repair, and metabolic balance. For research use only.
Research Tesamorelin — a synthetic growth hormone–releasing hormone (GHRH) analog studied for its roles in stimulating GH secretion and regulating metabolic pathways. For research use only.
No products in the cart.
Notifications
